AL

Abhijit Laxmikant Chidrawar

Active Director Director DIN 10823771
DIN 10823771 First appointment Oct 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhijit Laxmikant Chidrawar

Data last updated:

Abhijit Laxmikant Chidrawar is a Director at Vighnaharta Multispeciality Hospital Private Limited (since 2024). The company operates in Paper.

DIN 10823771
Primary Designation Director
Industry Paper
First Appointment 29 Oct 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Oct 20242024Active

Board colleagues of Abhijit Laxmikant Chidrawar

Directorship timeline

Open interactive timeline →
Vighnaharta Multispeciality Hospital Private Limited
Premium access

Shareholding and investment profile for Abhijit Laxmikant Chidrawar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhijit Laxmikant Chidrawar

Abhijit Laxmikant Chidrawar currently holds 1 directorship: Vighnaharta Multispeciality Hospital Private Limited (Director, since 29 Oct 2024).

Abhijit Laxmikant Chidrawar was first appointed on 29 Oct 2024 as Director at Vighnaharta Multispeciality Hospital Private Limited.

The current boards of Abhijit Laxmikant Chidrawar's companies include Laxmikant Pampatwar (Vighnaharta Multispeciality Hospital Private Limited), Sudhanshu Santuk Deshmukh (Vighnaharta Multispeciality Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available